Nationality Indian Years active 1984 - Present | Occupation Medical Researcher Spouse(s) Ms. Uma Devi Pareek | |
Children Mr. Abhishek Pareek & Mr. Aditya Pareek | ||
Dr. Anil Pareek; (born 10th Jan 1957) is active in the field of Medical Affairs and Clinical Research. He has given his more than 28 yrs to the field of Medicine and his contribution in Diabetes and blood pressure is remarkable. His experience includes academics and clinical practice. Diabetes, cardio-metabolic disorders, asthma and obstructive airways diseases are the area of Expertise for Dr. Pareek. He has a sound knowledge of drug development process and its clinical trial methodology. Understanding and identifying therapy gaps to create scope for innovative products and meet business requirements are the key role of Dr. Pareek.
Contents
Dr. Pareek is currently President, Medical Affairs and Clinical Research at Ipca laboratories Ltd, Mumbai, India. Ipca is a fully integrated pharmaceutical organization with a turnover of multi million US Dollars and operations in more than 110 countries all over the world.
Education
Dr. Pareek received his MBBS degree in October 1978 from Topiwala National Medical College and Nair Hospital, University of Mumbai. He received his M.D. in Internal Medicine and Therapeutics in October 1983 from Topiwala National Medical College and Nair Hospital, University of Mumbai
Career
Dr. Pareek Started his career as a resident doctor in Medicine, Pediatrics, and Radiology at BLY Nair Hospital, Mumbai in March 1980. Subsequently, he worked as a faculty at Topiwala National Medical College, Mumbai. He also worked as Consultant Physician at Ministry of Health, Saudi Arabia. With the passing years Dr. Pareek has been associated with several leading pharmaceutical companies in India. He has several Publications to his credit in leading international peer reviewed journals.
Currently Dr. Pareek is working as President, Medical Affairs and Clinical Research in Ipca Laboratories Ltd.
Early and Personal Life
Dr. Anil Pareek was born in Mumbai, Maharashtra. His Father Mr. Hanuman Prasad Pareek served a renowned textile mills during 50's to 80's in Mumbai. Dr Pareek is married to Ms. Uma Devi Pareek. The couple have two children Abhishek Pareek and Aditya Pareek.
Achievements
A man who knows the time management and balancing act so well that after being The President in his current organization also has never stopped him from publishing new articles in scientific journals. This is the only reason why Dr. Pareek holds six patents for novel drug combinations in the area of metabolic disorders.
He has been successful in establishing the role of hydroxychloroquine in metabolic disorders and for the first time in the world, hydroxychloroquine has been approved for the treatment of type 2 diabetes mellitus in India.
With his contribution, several products were introduced for the first in India e.g. Hydroxychloroquine (DMARD), Beta-Arteether, Aceclofenac, Norfloxacin, Combination of Atenolol and Nifedipine, Alprazolam, and Midazolam.
He has helped in outsourcing of several products like Metoprolol extended release + Amlodipine, Metoprolol XL + Ramipril, Cefoperazone + sulbactam (2:1 combination) and Quetiapine Sustained Released to various multi-national and Indian pharmaceutical companies.
He has several publications in leading medical journals on his name
Awards
Apart from his knowledge and skills, Dr. Pareek has unique hold as a pharmaceutical scientist and medical practitioner. This has rightfully helped him in getting recognition and Awards. In 2008, he received "New Investigator Travel Award" for participating at Jackson Cardiovascular Renal Meeting, 2008, at The University of Mississippi Medical center, Jackson Mississippi.
Dr. Anil Pareek received his second award "IDMA Margi Memorial Best Patent Awards 2014-15" for hydroxychloroquine combinations in treatment of diabetes.
Working with Ipca Laboratories Ltd. Dr. Pareek has received "Clinical and Research Excellence (CARE) award 2016" for the category "Clinical Trial Results of the Year" Sponsored by Informa on 27 April, 2016 at State Room, Boston, US.
Patents
- Patentee for a novel pharmaceutical composition of statin with disease modifying anti-rheumatic drug vide patent no 206561 granted by government of India Patent Office. Provisional Patent Application No. 154/MUM/2003
- Patentee for a novel fixed dose combination of hydroxychloroquine with antidiabetic drugs for the treatment of diabetes. Provisional Patent Application No. 2047/MUM/2008, US patent no 13/119648 (US20110230501), European patent no.09821690, (EP2331099).
- Patentee for a pharmaceutical composition of hydroxychloroquine, insulin sensitizing agent and lipid lowering agent for treatment / prophylaxis of non-alcoholic fatty liver disease. Indian patent 2375/mum/2009, US patent 13/501,342 (US20120202849A1), European patent 10826234.6 (EP2488180).
- A pharmaceutical composition of Hydroxychloroquine and DPP-IV inhibitor for preventing slowing the progressionof delaying improving restoring or treating condition or a disease resulting from metabolic disorders. India 2001/MUM/2009, US patent 14/152,568 (US20141284402A1) European patent 12839920.1 (EP2731610A1), Japanese patent JP2014-519695, Canadian patent 201280034486.X (CN103648498).
- Treatment and prophylaxis of kidney disease Indian patent 684/MUM/2013, European patent 14763103.0, US patent in process.
- HCQS for prophylaxis and treatment of statin induced diabetes India 1454/MUM/2015